PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Clinical trial NCT07477418 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07477418
Sponsor: University of Vermont
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic Cancer Pancreatic Neoplasms

Start date: 2026-12-01
Primary completion: 2030-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.